← Coverage
RXRX Recursion
Biotech · NASDAQ · 한국어 페이지
AI drug discovery. No meaningful trade proxy — driven by clinical and partnership news.
Current-quarter revenue estimate
No current-quarter estimate — no data flow moves closely enough with this company's revenue.
Key supply-chain flow
No monthly flow with enough history.
Mapped data flows
How each flow moves with quarterly revenue (year-over-year correlation, flow leading by 0–2 quarters).
| Flow | Stage | Revenue link | Correlation | Data to |
|---|
A ≥0.7 direct link · B ≥0.5 linked · C ≥0.3 industry context · D weak. Fewer than 8 comparable quarters caps the grade at C.